{"id":"W4312212850","doi":"10.3389/fimmu.2022.1110388","title":"Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies","year":2022,"lang":"en","type":"erratum","venue":"Frontiers in Immunology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"","keywords":"Tolerability; Medicine; Antibody; Immunology; Pediatrics; Adverse effect; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001916958,0.002239101,0.002743194,0.002046508,0.001422315,0.00194029,0.002068655,0.00623506,0.01887569],"category_scores_gemma":[0.01343926,0.0007758796,0.001480997,0.001181107,0.001488709,0.0008621091,0.0005305859,0.00646067,0.01732846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002759968,"about_ca_system_score_gemma":0.001979967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01251354,"about_ca_topic_score_gemma":0.0188682,"domain_scores_codex":[0.9981902,0.0003768348,0.000301408,0.0002374617,0.000721121,0.0001729494],"domain_scores_gemma":[0.9906614,0.002450537,0.0005857046,0.0004601345,0.005156598,0.0006855912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000643689,0.00002251025,0.00008498577,0.0001589506,0.00001921584,0.0003998647,0.000006969699,0.00004368672,0.00006626719,0.0001710119,0.989422,0.009540137],"study_design_scores_gemma":[0.0002335661,0.0002371135,0.004130092,0.0006533777,0.000192666,0.002342024,0.00004940566,0.0005309256,0.0008455945,0.0009075984,0.9898229,0.00005469292],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0003311627,0.007021732,0.0002915027,0.04949983,0.9348076,0.00004837817,0.0003974157,0.0002030798,0.007399419],"genre_scores_gemma":[0.01352318,0.02189034,0.001811705,0.1296989,0.6182691,0.0002470547,0.001097467,0.0003532353,0.213109],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01887569,"threshold_uncertainty_score":0.06314546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01143827183547345,"score_gpt":0.231307563837204,"score_spread":0.2198692920017306,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}